Forty-seven (78.3%) out of 60 EPNEC patients and 70 (85.4%) out of 82 SCLC patients had tumours with high expression of ERCC1 (H-score ≥ 200) (p = 0.28). This evidence concerns the gene ERCC1 and small cell lung carcinoma.